-
COVID-19 vaccines pre-prepared in syringes can be safely transported
worldpharmanews
June 21, 2021
One of the main reasons for the hold-ups in the mass vaccination campaigns against COVID-19 are the precautions that must be taken regarding the handling of the vaccines and their administration.
-
Ease supply of ingredients for making COVID vaccines to India, others: Macron
expresspharma
June 15, 2021
He also favoured a proposal by India and South Africa at the World Trade Organisation for a temporary lift on the patents on COVID-19 vaccines and said France will raise the issue at the G7 Summit.
-
Emirates SkyCargo Expands Pharma Cool Chain Capabilities
contractpharma
June 11, 2021
Emirates SkyCargo is expanding its temperature-sensitive pharma and vaccine handling capabilities in Dubai with the extension of its fully automated cool room at its EU GDP-certified dedicated pharma facility at Dubai International Airport.
-
Cigna International survey finds perception of safety and acceptance of COVID-19 vaccines improving
prnasia
June 02, 2021
Cigna's International Markets business today published the second edition of its COVID-19 Vaccine Perception Study which shows that overall rates of vaccines acceptance have increased from 63% to 66% in a single month.
-
Industry hustling to ensure supply of recombinant vector COVID-19 vaccines
europeanpharmaceuticalreview
May 26, 2021
A new report suggests pharma is working hard to combat worldwide viral vectors shortage that could threaten the COVID-19 vaccine rollout.
-
Global biopharmaceutical industry sees upcoming World Health Assembly as a critical milestone to take stock of progress achieved and discuss enablers for future pandemic preparedness
firstwordpharma
May 25, 2021
The 74thWorld Health Assembly, taking place in extraordinary circumstances, represents a critical milestone in analyzing the world's response to the COVID-19 pandemic.
-
Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Indian Variant: Study
drugs
May 25, 2021
Two doses of the Pfizer and AstraZeneca COVID-19 vaccines are effective against the coronavirus variant first identified in India, according to a new report from Public Health England.
-
Bio/pharma industry strives to solve shortage of viral vector used in many COVID-19 vaccines: GlobalData
expresspharma
May 25, 2021
Viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the requirement for complex specialist facilities.
-
Sanofi to provide fill and finish manufacturing support for Moderna vaccine
cphi-online
May 24, 2021
French company is now providing manufacturing capacity to support three different COVID-19 vaccines
-
Moderna might manufacture COVID-19 vaccines in Japan
expresspharma
May 24, 2021
Moderna Inc is considering manufacturing its COVID-19 vaccine in Japan, Nikkei newspaper reported, citing an interview with Stephane Bancel, the company’s CEO.